Skip to main content
    G

    Globus Medical (GMED)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $70.51
    -1.63 (-2.26%)

    Market Cap: $9.57B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Globus Medical (GMED) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Globus Medical reported revenue of $2.94B for the fiscal year ended Dec 31, 2025, up 16.7% from the year before. That year, net income was $537.87M with a net margin of 18.3%, operating cash flow was $753.45M and free cash flow was $588.77M. The quarter ended Sep 30, 2026 had revenue of $763.72M and net income of $141.17M.

    Revenue and Margins

    The operating margin was 16.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $563.99M, a compound annual rate of 20.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$2.94B+16.7%67.4%16.3%18.3%
    Dec 2024$2.52B+60.6%58.9%6.6%4.1%
    Dec 2023$1.57B+53.3%65.1%8.5%7.8%
    Dec 2022$1.02B+6.8%74.2%22.3%18.6%
    Dec 2021$958.10M+21.4%75.0%17.9%15.6%
    Dec 2020$789.04M+0.5%72.4%14.1%13.0%
    Dec 2019$785.37M+10.2%77.1%21.9%19.8%
    Dec 2018$712.97M+12.1%77.6%23.7%21.9%
    Dec 2017$635.98M+12.8%76.3%25.4%16.9%
    Dec 2016$563.99MN/A76.1%27.3%18.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 422.3% from the year before. In the quarter ended Sep 2026, net income rose 18.7% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$2.94B$2.52B$1.57B$1.02B$958.10M$789.04M$785.37M$712.97M$635.98M$563.99M
    Cost of revenue$957.80M$1.04B$548.17M$263.73M$239.22M$217.46M$179.97M$159.41M$150.45M$134.71M
    Gross profit$1.98B$1.48B$1.02B$759.12M$718.88M$571.58M$605.39M$553.56M$485.52M$429.29M
    Research and development$147.25M$163.75M$124.01M$73.02M$97.35M$84.52M$60.07M$55.50M$43.68M$44.53M
    Operating income$479.82M$165.99M$133.14M$227.95M$171.95M$111.43M$171.99M$169.32M$161.84M$154.14M
    Net income$537.87M$102.98M$122.87M$190.17M$149.19M$102.28M$155.21M$156.47M$107.35M$104.34M
    EBITDA$900.88M$620.35M$370.62M$302.43M$243.76M$175.41M$224.19M$218.63M$208.06M$197.06M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$763.72M$789.61M$759.85M$826.42M$769.05M$745.34M$598.12M$657.29M$625.71M$629.69M$606.67M$616.53M
    Gross profit$530.80M$548.17M$525.79M$565.31M$516.51M$496.58M$402.72M$393.86M$355.19M$369.65M$365.18M$351.05M
    Operating income$177.55M$182.43M$150.39M$169.34M$137.36M$76.11M$97.00M$60.27M$48.10M$49.62M$8.00M$10.12M
    Net income$141.17M$151.57M$124.30M$140.59M$118.97M$202.85M$75.46M$26.50M$51.84M$31.76M-$7.12M$15.03M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $14.74M by $511.42M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$5.30B$5.25B$5.09B$2.08B$1.96B$1.68B$1.53B$1.30B$1.08B$927.64M
    Current assets$2.13B$2.18B$1.92B$983.34M$864.52M$821.76M$687.47M$630.68M$620.34M$513.77M
    Cash and equivalents$526.16M$784.44M$467.29M$150.47M$193.07M$239.40M$195.72M$139.75M$118.82M$66.95M
    Total liabilities$729.51M$1.07B$1.09B$229.75M$215.88M$173.19M$129.63M$115.15M$110.72M$95.56M
    Short-term debt$14.74M$443.35M$0$2.54M$94.41M$88.69M$74.66M$4.51MN/AN/A
    Long-term debtN/AN/A$417.40M$0N/AN/AN/AN/A$0$0
    Shareholder equity$4.57B$4.18B$4.00B$1.85B$1.74B$1.51B$1.40B$1.19B$967.78M$832.08M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$5.53B$5.49B$5.44B$5.30B$5.10B$4.96B$4.71B$5.25B$5.09B$4.99B$4.94B$5.09B
    Total liabilities$731.94M$719.65M$707.24M$729.51M$696.82M$665.41M$623.08M$1.07B$1.02B$1.02B$1.02B$1.09B
    Cash and equivalents$441.27M$507.75M$560.95M$526.16M$371.77M$229.45M$461.27M$784.44M$622.77M$410.42M$354.06M$467.29M
    Shareholder equity$4.80B$4.77B$4.73B$4.57B$4.40B$4.30B$4.09B$4.18B$4.07B$3.98B$3.92B$4.00B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 78.1% of operating cash flow. Share repurchases came to 51.0% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$753.45M$520.64M$243.50M$178.47M$276.27M$198.79M$171.97M$181.64M$159.06M$147.82M
    Capital expenditures$164.68M$115.43M$78.27M$74.05M$56.90M$63.66M$70.75M$59.70M$51.30M$40.91M
    Free cash flow$588.77M$405.21M$165.22M$104.42M$219.38M$135.13M$101.22M$121.95M$107.75M$106.91M
    Share repurchases$300.45M$85.79M$225.56M$144.49M$0$104.67M$0$0N/AN/A
    Investing cash flow-$355.01M-$176.05M$302.97M-$110.36M-$375.94M-$117.32M-$140.28M-$193.03M-$111.28M-$162.74M
    Financing cash flow-$679.16M-$27.70M-$231.82M-$109.96M$54.15M-$38.66M$24.44M$32.57M$1.63M$470.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$265.23M$209.74M$202.36M$248.59M$249.69M$77.86M$177.30M$210.34M$203.65M$54.26M$52.39M$104.67M
    Capital expenditures$40.39M$33.17M$39.62M$46.20M$35.82M$46.56M$36.10M$17.11M$41.95M$27.80M$28.57M$22.88M
    Free cash flow$224.84M$176.57M$162.75M$202.39M$213.88M$31.30M$141.20M$193.23M$161.70M$26.46M$23.82M$81.79M
    Last 12 quarters

    Frequently Asked Questions About GMED

    What is Globus Medical's annual revenue?

    Globus Medical reported revenue of $2.94B for the fiscal year ended Dec 31, 2025.

    How fast is Globus Medical's revenue growing?

    Revenue was up 16.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 42.2%.

    Is Globus Medical profitable?

    Yes. Globus Medical reported net income of $537.87M for the fiscal year ended Dec 31, 2025, with a net margin of 18.3%.

    How much free cash flow does GMED generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $753.45M minus capital expenditures of $164.68M produced free cash flow of $588.77M.

    How much debt does Globus Medical have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $14.74M and cash and equivalents of $526.16M.